Full Text View
Tabular View
No Study Results Posted
Related Studies
Pilot Study of Atorvastatin in Children With Chronic Hyperlipidemia Secondary to Nephrotic Syndrome
This study has been completed.
Study NCT00004466   Information provided by Office of Rare Diseases (ORD)
First Received: October 18, 1999   Last Updated: June 23, 2005   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Conditions listed in this trial
Nephrotic Syndrome
Hyperlipidemia
Additional conditions recognized in this trial
Hyperlipidemias
Syndrome
More general conditions related to this trial
Disease
Dyslipidemias
Kidney Diseases
Lipid Metabolism Disorders
Metabolic Diseases
Nephrosis
Pathologic Processes
Urologic Diseases
Interventions listed in this trial
atorvastatin
More general drug interventions related to this trial
Anticholesteremic Agents
Antilipemic Agents
Antimetabolites
Enzyme Inhibitors
Hydroxymethylglutaryl-CoA Reductase Inhibitors
Molecular Mechanisms of Pharmacological Action
Pharmacologic Actions
Therapeutic Uses
Sponsors listed in this trial
National Institute of Diabetes and Digestive and Kidney Diseases (NIDDK)
Southwest Pediatric Nephrology Study Group


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services